BUCHI J KEVIN 4
4 · Benitec Biopharma Inc. · Filed Mar 3, 2025
Insider Transaction Report
Form 4
BUCHI J KEVIN
Director
Transactions
- Exercise/Conversion
Common Warrants (right to buy)
2025-02-27−51,813→ 0 totalExercise: $3.86From: 2023-08-11Exp: 2028-08-11→ Common Stock (51,813 underlying) - Exercise/Conversion
Common Stock
2025-02-27$3.86/sh+51,813$199,998→ 103,910 total